Medical Cannabis and Menopause UK — Can It Help?
Growing numbers of UK women explore medical cannabis for menopause symptoms including hot flushes, insomnia and anxiety. Here is what the evidence says.
Quick Navigation
Why Women Are Asking About Medical Cannabis for Menopause
Menopause affects around 13 million women in the UK at any given time, yet many find that conventional treatments — hormone replacement therapy (HRT), antidepressants, or sleep aids — do not fully address their symptoms, or come with side effects they wish to avoid. In this context, interest in medical cannabis as a complementary or alternative option has grown significantly over the past three years.
This guide explains what the current evidence shows, how UK patients can access medical cannabis legally, and what to expect from the prescribing process.
Common Menopause Symptoms and the Endocannabinoid System
The endocannabinoid system (ECS) plays a role in regulating sleep, mood, body temperature, pain perception and immune function — all areas disrupted during perimenopause and menopause. Oestrogen levels influence ECS activity, which is one reason researchers are investigating whether cannabinoids could help rebalance some of the physiological changes that occur during this life stage.
Symptoms Patients Most Commonly Report Addressing With Cannabis
- Insomnia and disturbed sleep: The most frequently cited benefit in patient surveys, with THC and CBD both studied for sleep latency and duration.
- Anxiety and mood changes: CBD-dominant products are often trialled first; low-dose THC may assist in patients with severe anxiety unresponsive to CBD alone.
- Chronic musculoskeletal pain: Joint pain and fibromyalgia-type symptoms are recognised indications for UK medical cannabis prescriptions.
- Hot flushes: Preclinical evidence suggests cannabinoids interact with thermoregulatory pathways, though robust human trials remain limited.
What the Evidence Currently Shows
Research specifically targeting menopause and cannabis is still at an early stage. However, broader clinical evidence supports medical cannabis for chronic pain, anxiety disorders and insomnia — conditions that frequently overlap with menopause. A 2023 survey by the British Menopause Society found that approximately 6% of respondents had tried cannabis for menopause symptoms, most reporting subjective improvement in sleep and mood.
The absence of large randomised controlled trials means that medical cannabis is not a first-line recommendation. UK prescribers typically consider it when established treatments have been inadequate or poorly tolerated.
Getting a Prescription in the UK
Medical cannabis is available on private prescription from a licensed specialist. GPs cannot prescribe it directly, but they can refer patients, or patients can self-refer to a UK cannabis clinic. At your appointment, the specialist will review your medical history, current medications, and symptom burden to determine whether cannabis is appropriate.
Many clinics now operate telehealth consultations, making the process accessible regardless of where in the UK you live. Initial consultation fees typically range from £50 to £150, with monthly prescription costs of £100–£400 depending on the product.
Choosing the Right Product
For menopause-related symptoms, prescribers most commonly start with a CBD-dominant oil taken sublingually before bed to address sleep and anxiety. If sleep does not improve sufficiently, a low-dose THC product may be added under close supervision. Browse available products to understand the range of options currently licensed in the UK.
Important Interactions to Discuss With Your Doctor
- HRT medications — no major interactions documented but monitoring is recommended.
- Blood pressure medications — cannabis can cause transient drops in blood pressure.
- Antidepressants — particularly SSRIs, where CYP450 enzyme interactions may occur.
Realistic Expectations
Medical cannabis is not a cure for menopause, and results vary between individuals. The majority of UK patients report that it helps manage specific symptoms rather than eliminating them entirely. A titration period of four to eight weeks is normal before optimal dosing is established. Regular follow-up with your prescribing clinic is essential.
Read more about the titration process in our titration guide.
Key Takeaways
- Medical cannabis is not a first-line menopause treatment but may be appropriate when conventional options have failed.
- Sleep, anxiety and chronic pain are the symptoms with the strongest supporting evidence.
- Prescriptions are available privately from licensed UK specialists — GPs cannot prescribe directly.
- CBD-dominant products are typically trialled before THC-containing options.
- Always disclose all medications to your prescriber to identify potential interactions.